Additive

K2M posted 1Q17 revenue of US $61.9MM, +9.9% vs. 1Q16. (U.S. $46.2MM, +9.5%; ex-U.S. $15.7MM, +11.1%) Following 1Q, the company received key product registrations from Japan's Pharmaceuticals and Medical Devices Agency, and can now implement a new distribution strategy in that region.

ORTHOWORLD estimates Stryker's 1Q17 orthopaedic revenue at US $1,612.3MM, +6.0% from 1Q16.

NuVasive reported 1Q17 revenue of US $249.9MM, +16.2% vs. 1Q16. (U.S. $214.2MM, +13.7%; ex-U.S. $35.6MM, +33.3%)